BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 31255659)

  • 1. Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes.
    Huang C; Cintra M; Brennan K; Zhou M; Colevas AD; Fischbein N; Zhu S; Gevaert O
    EBioMedicine; 2019 Jul; 45():70-80. PubMed ID: 31255659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive.
    Zhu Y; Mohamed ASR; Lai SY; Yang S; Kanwar A; Wei L; Kamal M; Sengupta S; Elhalawani H; Skinner H; Mackin DS; Shiao J; Messer J; Wong A; Ding Y; Zhang L; Court L; Ji Y; Fuller CD
    JCO Clin Cancer Inform; 2019 Feb; 3():1-9. PubMed ID: 30730765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological image and gene expression pattern analysis for predicting molecular features and prognosis of head and neck squamous cell carcinoma.
    Chen L; Zeng H; Zhang M; Luo Y; Ma X
    Cancer Med; 2021 Jul; 10(13):4615-4628. PubMed ID: 33987946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma.
    Katsoulakis E; Yu Y; Apte AP; Leeman JE; Katabi N; Morris L; Deasy JO; Chan TA; Lee NY; Riaz N; Hatzoglou V; Oh JH
    Oral Oncol; 2020 Nov; 110():104877. PubMed ID: 32619927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an atypical etiological head and neck squamous carcinoma subtype featuring the CpG island methylator phenotype.
    Brennan K; Koenig JL; Gentles AJ; Sunwoo JB; Gevaert O
    EBioMedicine; 2017 Mar; 17():223-236. PubMed ID: 28314692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma.
    Bogowicz M; Riesterer O; Ikenberg K; Stieb S; Moch H; Studer G; Guckenberger M; Tanadini-Lang S
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):921-928. PubMed ID: 28807534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
    Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT-based Radiomic Signatures for Predicting Histopathologic Features in Head and Neck Squamous Cell Carcinoma.
    Mukherjee P; Cintra M; Huang C; Zhou M; Zhu S; Colevas AD; Fischbein N; Gevaert O
    Radiol Imaging Cancer; 2020 May; 2(3):e190039. PubMed ID: 32550599
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
    Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Ren S; Gaykalova D; Wang J; Guo T; Danilova L; Favorov A; Fertig E; Bishop J; Khan Z; Flam E; Wysocki PT; DeJong P; Ando M; Liu C; Sakai A; Fukusumi T; Haft S; Sadat S; Califano JA
    Int J Cancer; 2018 Nov; 143(10):2425-2436. PubMed ID: 30070359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine Learning Based Radiomic HPV Phenotyping of Oropharyngeal SCC: A Feasibility Study Using MRI.
    Sohn B; Choi YS; Ahn SS; Kim H; Han K; Lee SK; Kim J
    Laryngoscope; 2021 Mar; 131(3):E851-E856. PubMed ID: 33070337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures.
    Mes SW; van Velden FHP; Peltenburg B; Peeters CFW; Te Beest DE; van de Wiel MA; Mekke J; Mulder DC; Martens RM; Castelijns JA; Pameijer FA; de Bree R; Boellaard R; Leemans CR; Brakenhoff RH; de Graaf P
    Eur Radiol; 2020 Nov; 30(11):6311-6321. PubMed ID: 32500196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A CT-based Deep Learning Radiomics Nomogram for the Prediction of EGFR Mutation Status in Head and Neck Squamous Cell Carcinoma.
    Zheng YM; Pang J; Liu ZJ; Yuan MG; Li J; Wu ZJ; Jiang Y; Dong C
    Acad Radiol; 2024 Feb; 31(2):628-638. PubMed ID: 37481418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging based radiomics signature for the preoperative discrimination of stage I-II and III-IV head and neck squamous cell carcinoma.
    Ren J; Tian J; Yuan Y; Dong D; Li X; Shi Y; Tao X
    Eur J Radiol; 2018 Sep; 106():1-6. PubMed ID: 30150029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three distinct genomic subtypes of head and neck squamous cell carcinoma associated with clinical outcomes.
    Lee DJ; Eun YG; Rho YS; Kim EH; Yim SY; Kang SH; Sohn BH; Kwon GH; Lee JS
    Oral Oncol; 2018 Oct; 85():44-51. PubMed ID: 30220319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Radiomics Approach to Identify Immunologically Active Tumor in Patients with Head and Neck Squamous Cell Carcinomas.
    Nguyen TM; Bertolus C; Giraud P; Burgun A; Saintigny P; Bibault JE; Foy JP
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary Computed Tomography Radiomics Model for Predicting Pretreatment CD8+ T-Cell Infiltration Status for Primary Head and Neck Squamous Cell Carcinoma.
    Wang CY; Ginat DT
    J Comput Assist Tomogr; 2021 Jul-Aug 01; 45(4):629-636. PubMed ID: 34519454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylated genomic loci encoding microRNA as a biomarker panel in tissue and saliva for head and neck squamous cell carcinoma.
    Cao Y; Green K; Quattlebaum S; Milam B; Lu L; Gao D; He H; Li N; Gao L; Hall F; Whinery M; Handley E; Ma Y; Xu T; Jin F; Xiao J; Wei M; Smith D; Bornstein S; Gross N; Pyeon D; Song J; Lu SL
    Clin Epigenetics; 2018; 10():43. PubMed ID: 29636832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI-based radiomic signature as predictive marker for patients with head and neck squamous cell carcinoma.
    Yuan Y; Ren J; Shi Y; Tao X
    Eur J Radiol; 2019 Aug; 117():193-198. PubMed ID: 31307647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-objective radiomics model for the prediction of locoregional recurrence in head and neck squamous cell cancer.
    Wang K; Zhou Z; Wang R; Chen L; Zhang Q; Sher D; Wang J
    Med Phys; 2020 Oct; 47(10):5392-5400. PubMed ID: 32657426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.